Retatrutide 20mg

Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is researched for its complex interaction with metabolic signaling pathways and endocrine regulatory mechanisms in preclinical studies.

FDA Disclaimer: The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The products offered are not intended to diagnose, treat, cure, or prevent any disease. All products are intended for laboratory research use only and are not for human consumption.